A Consideration of Fixed Dosing Versus Body Size-Based Dosing Strategies for Chimeric Antigen Receptor T-Cell Therapies.
Clin Pharmacol Drug Dev
; 11(10): 1130-1135, 2022 10.
Article
in En
| MEDLINE
| ID: mdl-36094760
Key words
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Receptors, Chimeric Antigen
Limits:
Humans
Language:
En
Journal:
Clin Pharmacol Drug Dev
Year:
2022
Type:
Article
Affiliation country:
United States